Clinical trial
Glycine Treatment of Prodromal Symptoms
NCT00268749 · Yale University, Other · Completed
Key facts
| NCT number | NCT00268749 |
|---|---|
| Title | Glycine Treatment of Prodromal Symptoms |
| Official title | Glycine Treatment of Prodromal Symptoms |
| Lead sponsor | Yale University, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | glycine |
| Enrollment | 10 |
| Start date | Jul 1, 2002 |
| Primary completion | Nov 1, 2004 |
| Completion | Nov 1, 2004 |
| First posted | Dec 22, 2005 |
| Last update posted | Mar 29, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: